Amgen (AMGN) Prepaid Assets (2009 - 2026)
Amgen (AMGN) posted quarterly Prepaid Assets of $4.1 billion for Q1 2026, up 26.24% year-over-year from $3.3 billion in Q1 2025, and little changed quarter-over-quarter from $4.1 billion in Q4 2025.
Amgen (AMGN) Prepaid Assets (2009 - 2026) Analysis & Trends
Amgen's Prepaid Assets history runs 18 years deep, the most recent figure standing at $4.1 billion for Q1 2026.
- In Q1 2026, Prepaid Assets rose 26.24% year-over-year to $4.1 billion; the TTM figure through Mar 2026 stood at $4.1 billion (up 26.24% YoY), while the FY2025 annual figure was $4.1 billion, up 26.12% from the prior year.
- Prepaid Assets for Q1 2026 stood at $4.1 billion, roughly flat from $4.1 billion in the prior quarter.
- The five-year high for Prepaid Assets was $4.1 billion in Q4 2025, with the low at $2.3 billion in Q2 2022.
- The 5-year median for Prepaid Assets is $2.8 billion (2024), against an average of $3.0 billion.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets decreased 6.81% in 2022, then increased 28.06% in 2024.
- Amgen's Prepaid Assets stood at $2.4 billion in 2022, then advanced by 8.96% to $2.6 billion in 2023, then gained by 25.94% to $3.3 billion in 2024, then advanced by 26.12% to $4.1 billion in 2025, then retreated by 0.48% to $4.1 billion in 2026.
- Business Quant data shows AMGN's Prepaid Assets at $4.1 billion in Q1 2026, $4.1 billion in Q4 2025, and $3.6 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.53 Bn |
| Mar 31, 2026 | 4.11 Bn |
| Dec 31, 2025 | 4.13 Bn |
| Sep 30, 2025 | 3.60 Bn |
| Jun 30, 2025 | 3.42 Bn |
| Mar 31, 2025 | 3.26 Bn |
| Dec 31, 2024 | 3.28 Bn |
| Sep 30, 2024 | 3.08 Bn |
| Jun 30, 2024 | 2.98 Bn |
| Mar 31, 2024 | 2.82 Bn |
| Dec 31, 2023 | 2.60 Bn |
| Sep 30, 2023 | 2.57 Bn |
| Jun 30, 2023 | 2.32 Bn |
| Mar 31, 2023 | 2.40 Bn |
| Dec 31, 2022 | 2.39 Bn |
| Sep 30, 2022 | 2.50 Bn |
| Jun 30, 2022 | 2.26 Bn |
| Mar 31, 2022 | 2.49 Bn |
| Dec 31, 2021 | 2.37 Bn |
| Sep 30, 2021 | 2.54 Bn |